Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

QGEN

Qiagen NV (QGEN)

Qiagen NV
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:QGEN
일자시간출처헤드라인심볼기업
2024/05/0805:05GlobeNewswire Inc.QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensicsNYSE:QGENQiagen NV
2024/05/0305:05GlobeNewswire Inc.QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applicationsNYSE:QGENQiagen NV
2024/04/3005:05GlobeNewswire Inc.QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidanceNYSE:QGENQiagen NV
2024/04/2505:05GlobeNewswire Inc.QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceNYSE:QGENQiagen NV
2024/04/0922:48GlobeNewswire Inc.QIAGEN N.V. to release results for Q1 2024 and hold webcastNYSE:QGENQiagen NV
2024/04/0405:05GlobeNewswire Inc.QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024NYSE:QGENQiagen NV
2024/03/2605:05GlobeNewswire Inc.QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemNYSE:QGENQiagen NV
2024/03/1905:05GlobeNewswire Inc.QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsNYSE:QGENQiagen NV
2024/03/1118:59GlobeNewswire Inc.QIAGEN announces Form 20-F annual report filing for 2023 resultsNYSE:QGENQiagen NV
2024/02/2807:44GlobeNewswire Inc.QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discoveryNYSE:QGENQiagen NV
2024/02/2806:05GlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
2024/02/1606:05GlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
2024/02/0823:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
2024/02/0706:05GlobeNewswire Inc.QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitabilityNYSE:QGENQiagen NV
2024/01/2600:00GlobeNewswire Inc.QIAGEN announces partnership with Penn State University to advance microbiome sciencesNYSE:QGENQiagen NV
2024/01/2406:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:QGENQiagen NV
2024/01/1906:05GlobeNewswire Inc.QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 millionNYSE:QGENQiagen NV
2024/01/1121:53GlobeNewswire Inc.QIAGEN N.V. to release results for Q4 2023 and hold webcastNYSE:QGENQiagen NV
2024/01/0823:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
2024/01/0816:00GlobeNewswire Inc.QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular SystemsNYSE:QGENQiagen NV
2024/01/0803:07GlobeNewswire Inc.QIAGEN announces plans to return approximately $300 million to shareholdersNYSE:QGENQiagen NV
2024/01/0506:05GlobeNewswire Inc.QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics businessNYSE:QGENQiagen NV
2024/01/0316:00GlobeNewswire Inc.QIAGEN expands business in Middle East with new regional headquarters and major projectsNYSE:QGENQiagen NV
2023/12/0106:05GlobeNewswire Inc.DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogyNYSE:QGENQiagen NV
2023/11/1606:05GlobeNewswire Inc.QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolationNYSE:QGENQiagen NV
2023/11/1006:05GlobeNewswire Inc.QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customersNYSE:QGENQiagen NV
2023/11/0706:05GlobeNewswire Inc.QIAGEN launches complete Sample to Insight workflow for microbiome researchNYSE:QGENQiagen NV
2023/11/0221:00PR Newswire (US)QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI SystemNYSE:QGENQiagen NV
2023/11/0221:00GlobeNewswire Inc.QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI SystemNYSE:QGENQiagen NV
2023/10/3105:05GlobeNewswire Inc.QIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CERNYSE:QGENQiagen NV
 검색 관련기사 보기:NYSE:QGEN